Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
21/06/2025
Fed's Dale: There are multiple possibilities for the extent to which tariffs are passed on to consumers.
Latest
4 m ago
Henan: The summer planting season is basically over, and the area for autumn crops is stable at more than 76 million mu.
5 m ago
These office "black technology" may have leakage risks, the National Security Department: Don't let video conferences become "live broadcasts"
5 m ago
Market news: Toyota will increase car prices in the United States starting from July.
7 m ago
Novo Nordisk releases early results of clinical trial for the blood sugar-lowering drug Amycretin. Amycretin shows signs of improving blood sugar levels. In the study, Amycretin has shown a weight reduction effect of 24.3%.
7 m ago
Norway and Nord released the early results of the clinical trial for the hypoglycemic drug Amycretin. Amycretin showed signs of improving blood sugar levels. In the study, Amycretin demonstrated a weight loss effect of 24.3%.
See all latest